Stay updated on IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.

Latest updates to the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA newer revision tag (v3.6.3) was added to the study record history, indicating a minor update to the page; the previous revision (v3.6.2) was superseded in the log.SummaryDifference0.1%

- Check16 days agoChange DetectedThe record history gained new entries noting updates to Contacts/Locations and Study Status (version 11, Revision: v3.6.2) on 2026-06-23, while an earlier revision entry (Revision: v3.6.0 dated 2026-06-08) was removed.SummaryDifference0.6%

- Check31 days agoChange DetectedNew entries were added to the history for core study sections (Eligibility, Arms and Interventions, Study Description, Study Status) and navigation/contacts (Check who can join, Find Contact Information, Contacts/Locations) with a new revision tag (Revision: v3.6.0) and June 2026 dates; an older revision note (Revision: v3.5.5) and its date were removed.SummaryDifference1%

- Check38 days agoChange DetectedThe history page now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a system-wide update to the page version. This change is a metadata update reflecting a new release of the ClinicalTrials.gov page rather than content changes.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history page now displays a new revision version (v3.5.4) in place of the previous v3.5.3, indicating an updated release of the page's UI or metadata.SummaryDifference0.1%

- Check60 days agoChange DetectedNew governance-related sections—Contacts/Locations, Oversight, and Study Status—were added in the 2026-05-13 update to the Record History. The update expands the data fields shown in the study record versions to include contact, oversight, and status information.SummaryDifference0.6%

Stay in the know with updates to IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.